Synthesis and anticancer activities of a novel class of mono- and di-metallic Pt(II)(salicylaldiminato)- (DMSO or Picolino)Cl complexes

Rahman, Faiz-Ur; Ali, Amjad; Guo, Rong; Zhang, Yun-Chang; Wang, Hui; Lia, Zhan-Ting; Zhang, Dan-Wei

doi:10.1039/c4dt03018d

Article (Scientific journals)

Synthesis and anticancer activities of a novel class of mono- and di-metallic Pt(II)(salicylaldiminato)- (DMSO or Picolino)Cl complexes

Rahman, Faiz-Ur; Ali, Amjad; Guo, Rong et al.

2015 • In Dalton Transactions

Peer reviewed

Permalink
https://hdl.handle.net/2268/182210

DOI
10.1039/c4dt03018d

PubMed
25510629

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Dalton_Trans.,_1.pdf

Author preprint (4.54 MB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Abstract :

[en] A series of novel Pt(II) complexes [cis- and trans-Pt(II)(salicylaldimine)(DMSO)Cl (C-1), trans-Pt(II)(salicylaldimine)( 4-picoline)Cl (C-2), Pt(II)(salicylaldimine)Cl (C-3), trans- and cis/trans-Pt2(II)(salicylaldimine) (DMSO)2Cl2 (C-4), trans-Pt2(II)(salicylaldimine)(4-picoline)2Cl2 (C-5) was synthesized and characterized. The structures of C-1-cis, C-1-trans and C-3 were determined using a single crystal X-ray analysis. This class of Pt(II) complexes has been studied for their in vitro cytotoxicity in multiple human cancer cell lines, including breast (MCF-7), liver (HepG2), lung (A549), colon (HCT116) and cervical (Hela) cancers. C-1- trans, C-2 and C-4-trans showed significant cytotoxicity to these cancer cells comparable to cisplatin. A time- and dose-dependent MTT assay revealed that these complexes can suppress cell viability and cell proliferation. Mechanistically these complexes induced pro-apoptotic gene expression such as BAX, PUMA and NOXA and thereby enhanced apoptosis. Moreover, PARP cleavage in a dose-dependent manner indicated their cytotoxic effect against cancer cells. Apoptosis of cancer cells occurred through apoptotic pathways as explained by the cytometry analysis. The DNA unwinding properties of these active Pt(II) complexes were studied by gel electrophoresis using pBR322 plasmid DNA as a target. Changes in the morphology of cancer cells were also observed upon the addition of C-1-trans, C-2 and C-4-trans.

Disciplines :

Chemistry

Author, co-author :

Rahman, Faiz-Ur

Ali, Amjad ; Université de Liège > Département de pharmacie > Chimie médicale

Guo, Rong

Zhang, Yun-Chang

Wang, Hui

Lia, Zhan-Ting

Zhang, Dan-Wei

Language :

English

Title :

Synthesis and anticancer activities of a novel class of mono- and di-metallic Pt(II)(salicylaldiminato)- (DMSO or Picolino)Cl complexes

Publication date :

08 February 2015

Journal title :

Dalton Transactions

ISSN :

1477-9226

eISSN :

1477-9234

Publisher :

Royal Society of Chemistry (RSC), Cambridge, United Kingdom

Peer reviewed :

Peer reviewed

Available on ORBi :

since 01 June 2015

Statistics

Number of views

52 (4 by ULiège)

Number of downloads

1 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

L. A. Carey, E. C. Dees, L. Sawyer, L. Gatti, D. T. Moore, F. Collichio, D. W. Ollila, C. I. Sartor, M. L. Graham and C. M. Perou, Clin. Cancer Res., 2007, 13, 2329.
D. A. Berry, C. Cirrincione, I. C. Henderson, M. L. Citron, D. R. Budman, L. J. Goldstein, S. Martino, E. A. Perez, H. B. Muss and L. Norton, JAMA, 2006, 295, 1658.
D. P. Silver, A. L. Richardson, A. C. Eklund, Z. C. Wang, Z. Szallasi, Q. Li, N. Juul, C.-O. Leong, D. Calogrias, A. Buraimoh, A. Fatima, R. S. Gelman, P. D. Ryan, N. M. Tung, A. De Nicolo, S. Ganesan, A. Miron, C. Colin, D. C. Sgroi, L. W. Ellisen, E. P. Winer and J. E. Garber, J. Clin. Oncol., 2010, 28, 1145.
Z. C. Wang, M. Lin, L.-J. Wei, C. Li, A. Miron, G. Lodeiro, L. Harris, S. Ramaswamy, D. M. Tanenbaum and M. Meyerson, Cancer Res., 2004, 64, 64.
R. Rouzier, C. M. Perou, W. F. Symmans, N. Ibrahim, M. Cristofanilli, K. Anderson, K. R. Hess, J. Stec, M. Ayers and P. Wagner, Clin. Cancer Res., 2005, 11, 5678.
W. D. Foulkes, I. M. Stefansson, P. O. Chappuis, L. R. Bégin, J. R. Goffin, N. Wong, M. Trudel and L. A. Akslen, J. Natl. Cancer Inst., 2003, 95, 1482.
K. D. Mjos and C. Orvig, Chem. Rev., 2014, 114, 4540.
N. Muhammad and Z. Guo, Curr. Opin. Chem. Biol., 2014, 19, 144.
P. Chellan, T. Stringer, A. Shokar, P. J. Dornbush, G. Vazquez-Anaya, K. M. Land, K. Chibale and G. S. Smith, J. Inorg. Biochem., 2011, 105, 1562.
A. A. Bekhit, O. A. El-Sayed, T. A. Al-Allaf, H. Y. Aboul-Enein, M. Kunhi, S. M. Pulicat, K. Al-Hussain, F. Al-Khodairy and J. Arif, Eur. J. Med. Chem., 2004, 39, 499.
W. M. Motswainyana, M. O. Onani and A. M. Madiehe, Polyhedron, 2012, 41, 44.
A. R. Kapdi and I. J. Fairlamb, Chem. Soc. Rev., 2014, 43, 4751.
S. E. Karp, P. N. Tonin, L. R. Bégin, J. J.Martinez, J. C. Zhang, M. N. Pollak and W. D. Foulkes, Cancer, 1997, 80, 435.
J. N. Marcus, P. Watson, D. L. Page, S. A. Narod, G. M. Lenoir, P. Tonin, L. Linder-Stephenson, G. Salerno, T. A. Conway and H. T. Lynch, Cancer, 1996, 77, 697.
F. Eisinger, J. Jacquemier, C. Charpin, D. Stoppa-Lyonnet, B. Bressac-de Paillerets, J.-P. Peyrat, M. Longy, J.-M. Guinebretière, R. Sauvan and T. Noguchi, Cancer Res., 1998, 58, 1588.
D. Kovala-Demertzi, A. Papageorgiou, L. Papathanasis, A. Alexandratos, P. Dalezis, J. R. Miller and M. A. Demertzis, Eur. J. Med. Chem., 2009, 44, 1296.
D. Talancon, C. Lopez, M. Font-Bardia, T. Calvet, J. Quirante, C. Calvis, R. Messeguer, R. Cortes, M. Cascante, L. Baldoma and J. Badia, J. Inorg. Biochem., 2013, 118, 1.
B. Rosenberg, L. Vancamp, J. E. Trosko and V. H. Mansour, Nature, 1969, 222, 385.
B. Lippert, Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug, Verlag Helvetica Chimica Acta Zurich, Switzerland, 1999.
B. W. Harper, A. M. Krause-Heuer, M. P. Grant, M. Manohar, K. B. Garbutcheon-Singh and J. R. Aldrich- Wright, Chem. - Eur. J., 2010, 16, 7064.
R. E. Windsor, S. J. Strauss, C. Kallis, N. E. Wood and J. S. Whelan, Cancer, 2012, 118, 1856.
N. Milosavljevic, C. Duranton, N. Djerbi, P. H. Puech, P. Gounon, D. Lagadic-Gossmann, M. T. Dimanche-Boitrel, C. Rauch, M. Tauc, L. Counillon and M. Poet, Cancer Res., 2010, 70, 7514.
P. J. Loehrer and L. H. Einhorn, Ann. Intern. Med., 1984, 100, 704.
R. S. Aroney, J. A. Levi and D. N. Dalley, Br. Med. J., 1981, 282, 2003.
S. E. Sherman and S. J. Lippard, Chem. Rev., 1987, 87, 1153.
F. Arnesano and G. Natile, Coord. Chem. Rev., 2009, 253, 2070.
J. Zhao, S. Gou and G. Xu, Inorg. Chim. Acta, 2014, 409, 310.
N. J. Wheate, S. Walker, G. E. Craig and R. Oun, Dalton Trans., 2010, 39, 8113.
A. Mishra, S. Chang Lee, N. Kaushik, T. R. Cook, E. H. Choi, N. Kumar Kaushik, P. J. Stang and K. W. Chi, Chem. - Eur. J., 2014, 20, 1.
L. Dvořák, I. Popa, P. Štarha and Z. Trávníèek, Eur. J. Inorg. Chem., 2010, 2010, 3441.
S. J. Berners-Price, Angew. Chem., Int. Ed., 2011, 50, 804.
P. Virag, M. Perde-Schrepler, E. Fischer-Fodor, C. Tatomir, S. A. Dorneanu, V. I. Cernea and A. Irimie, Anti-Cancer Drugs, 2012, 23, 1032.
S. Kemp, N. Wheate, S. Wang, J. G. Collins, S. Ralph, A. Day, V. Higgins and J. Aldrich-Wright, J. Biol. Inorg. Chem., 2007, 12, 969.
S. Roy, K. D. Hagen, P. U. Maheswari, M. Lutz, A. L. Spek, J. Reedijk and G. P. van Wezel, ChemMedChem, 2008, 3, 1427.
C. M. Che, C. C. Kwok, S. W. Lai, A. F. Rausch, W. J. Finkenzeller, N. Zhu and H. Yersin, Chem. - Eur. J., 2010, 16, 233.
M. Proetto, W. Liu, A. Hagenbach, U. Abram and R. Gust, Eur. J. Med. Chem., 2012, 53, 168.
N. Komiya, T. Muraoka, M. Iida, M. Miyanaga, K. Takahashi and T. Naota, J. Am. Chem. Soc., 2011, 133, 16054.
N. Komiya, M. Okada, K. Fukumoto, D. Jomori and T. Naota, J. Am. Chem. Soc., 2011, 133, 6493.
F. Zheng, A. T. Hutton, C. G. van Sittert, J. R. Moss and S. F. Mapolie, Dalton Trans., 2013, 42, 11163.
A. E. Patterson, J. J. Miller, B. A. Miles, E. L. Stewart, J.-M. E. J. Melanson, C. M. Vogels, A. M. Cockshutt, A. Decken, P. Morin Jr. and S. A. Westcott, Inorg. Chim. Acta, 2014, 415, 88.
V. Y. Kukushkin, A. J. L. Pombero, C. M. P. Ferreira and L. I. Elding, in Dimethylsulfoxide Complexes of Platinum(II): K[PtCl3 (Me2SO)], cis-[PtCl2L(Me2SO)] (L = Me2SO, MeCN), [PtCl(μ-Cl)(Me2SO)]2, and [Pt(Me2SO)4](CF3SO3)2, ed. D. Coucouvanis, John Wiley & Sons, Inc., New York, 2002, vol. 33, pp. 189-196.
J. H. Price, A. N. Williamson, R. F. Schramm and B. B. Wayland, Inorg. Chem., 1972, 11, 1280.
R. Cini, A. Donati and R. Giannettoni, Inorg. Chim. Acta, 2001, 315, 73.
M. Crespo, R. Martín, T. Calvet, M. Font-Bardía and X. Solans, Polyhedron, 2008, 27, 2603.
J. Reedijk, Eur. J. Inorg. Chem., 2009, 2009, 1303.
J. Reedijk, Pure Appl. Chem., 1987, 59, 181.
H. Baruah, C. L. Rector, S. M. Monnier and U. Bierbach, Biochem. Pharmacol., 2002, 64, 191.
K. Samper, V. Rodríguez, E. Ortega-Carrasco, S. Atrian, J. Maréchal, N. Cutillas, A. Zamora, C. de Haro, M. Capdevila, J. Ruiz and Ò. Palacios, BioMetals, 2014, 1.
J. Stallock, K. Molyneaux, K. Schaible, C. M. Knudson and C. Wylie, Development, 2003, 130, 6589.
K. Nakano and K. H. Vousden, Mol. Cell, 2001, 7, 683.
E. Oda, R. Ohki, H. Murasawa, J. Nemoto, T. Shibue, T. Yamashita, T. Tokino, T. Taniguchi and N. Tanaka, Science, 2000, 288, 1053.
Y. Yang, S. Zhao and J. Song, Int. J. Biochem. Cell Biol., 2004, 36, 223.
A. I. Goranov, A. Gulati, N. Dephoure, T. Takahara, T. Maeda, S. P. Gygi, S. Manalis and A. Amon, Curr. Biol., 2013, 23, 1269.
B. Brandhagen, C. Tieszen, T. Ulmer, M. Tracy, A. Goyeneche and C. Telleria, BMC Cancer, 2013, 13, 35.
M. Sekimata, Y. Kabuyama, Y. Emori and Y. Homma, J. Biol. Chem., 1999, 274, 17757.
G. Sheldrick, Acta Crystallogr., Sect. A: Fundam. Crystallogr., 2008, 64, 112.
J. Chakraborty, M. Nandi, H. Mayer-Figge, W. S. Sheldrick, L. Sorace, A. Bhaumik and P. Banerjee, Eur. J. Inorg. Chem., 2007, 2007, 5033.
A. Ali, Z. Wang, J. Fu, L. Ji, J. Liu, L. Li, H. Wang, J. Chen, C. Caulin, J. N. Myers, P. Zhang, J. Xiao, B. Zhang and X. Li, Nat. Commun., 2013, 4, 2667.
G.-H. Lee, D.-S. Kim, H.-T. Kim, J.-W. Lee, C.-H. Chung, T. Ahn, J. M. Lim, I.-K. Kim, H.-J. Chae and H.-R. Kim, J. Biol. Chem., 2011, 286, 24743.